Table 1.
Effect of aza- and diaza-crown ethers on [Ca2+]i flux in human neutrophils.
Compound | EC50 (µM) (Efficacy, %) |
---|---|
5 | N.A. |
6 | N.A. |
7 | N.A. |
8 | 22.4 ± 4.3 (50) |
9 | N.A. |
10 | 9.7 ± 2.6 (35) |
11 | 15.6 ± 4.4 (40) |
12 | 23.8 ± 7.6 (25) |
13 | 6.9 ± 2.1 (25) |
14 | 9.5 ± 2.7 (40) |
15 | 4.7 ± 1.5 (110) |
16 | 15.7 ± 3.8 (25) |
17 | 15.9 ± 2.5 (50) |
18 | N.A. |
19 | N.A. |
20 | N.A. |
21 | 11.3 ± 3.1 (40) |
22 | N.A. |
23 | N.A. |
24 | N.A. |
25 | N.A. |
26 | N.A. |
27 | N.A. |
28 | N.A. |
N.A., no activity was found at concentration < 50 µM. Efficacy (in parentheses) is expressed as % of the response induced by 5 nM fMLF.